APELLIS PHARMACEUTICALS INC (APLS): Hedge Fund Ownership & Smart Money Signals (Q1 2026)

APELLIS PHARMACEUTICALS INC (APLS)

317 + Investors. Track Smart Money conviction in APLS. See who's accumulating, reducing, or initiating positions.

Smart Money Signals — APLS

Based on 320 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 3 quarters in a row

last 6Q

For 3 consecutive quarters, more hedge funds added APLS than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

🏔️

At the ownership peak (100% of max)

100% of all-time peak

320 hedge funds hold APLS right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.

🚀

Fast accumulation — +28% more funds vs a year ago

fund count last 6Q

+70 new funds entered over the past year (+28% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks. The peak was reached in just 3 quarters from the low — a sharp move.

🟡

Slight buying edge — 58% buying

219 buying157 selling

Last quarter: 219 funds bought or added vs 157 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

📈

More new buyers each quarter (+57 vs last Q)

new funds entering per quarter

Funds opening a new APLS position: 48 → 63 → 64 → 121. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.

🔒

48% of holders stayed for 2+ years

■ 48% conviction (2yr+) ■ 18% medium ■ 34% new

155 out of 320 hedge funds have held APLS for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

💰

Value +66% but shares only +6% — price-driven

Value

+66%

+6%

Last quarter: the total dollar value of institutional holdings rose +66%, but actual share count only changed +6%. The gap is explained by the stock's price rising — not new buying. Strong value growth with weak share growth means the rally is price momentum, not fresh institutional demand.

🚀

Acceleration phase — new buyers rushing in

46 → 48 → 63 → 64 → 121 new funds/Q

New funds entering each quarter: 48 → 63 → 64 → 121. The pace of institutional discovery is accelerating sharply. This is the 'hot idea' phase — the thesis is being passed from fund to fund. You are not late — the accumulation wave is still building.

🏛️

Deep conviction — 60% of holders stayed 2+ years

■ 60% veterans ■ 8% 1-2yr ■ 33% new

Of 337 current holders: 201 (60%) have held for over 2 years without selling. These are not momentum buyers — they have lived through drawdowns and stayed. A large veteran base acts as a stabilizing force during selloffs.

✅

Strong quality — 31% AUM from major funds

31% from top-100 AUM funds

49 of 320 holders rank in the top 100 by AUM, accounting for 31% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

4.2

out of 10

Moderate Exit Risk

Exit risk score 4.2/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Metric	All 13F Filers (2026 Q1)	Prior (2025 Q4)	Change
Funds Holding	317	281	12.81%
13F Shares	139M	131M	6.1%
Total Value	$5.49B	$3.31B	66.0%
New Positions	118	64	+54
Increased Positions	91	86	+5
Closed Positions	82	56	+26
Reduced Positions	72	99	-27
Total Calls	10	19	-47.37%
Total Puts	12	11	9.09%
PUT/CALL Ratio	1.2	0.58	Neutral

Metric

All 13F Filers (2026 Q1)

Prior (2025 Q4)

Change

Funds Holding

317

281

12.81%

13F Shares

139M

131M

6.1%

Total Value

$5.49B

$3.31B

66.0%

New Positions

118

+54

Increased Positions

Closed Positions

+26

Reduced Positions

-27

Total Calls

-47.37%

Total Puts

9.09%

PUT/CALL Ratio

1.2

0.58

Neutral

Institutional Holders (2026 Q1)

317 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in APLS. Verified SEC 13F-HR filings.

QUARTER:

FILTER:All New Added To Reduced No Change | Overweight >5%

Top 25 institutional holders of APLS — 2026 Q1 · Source: SEC Form 13F
#	Investor	% of Portfolio	Shares	Mkt Value
1	One68 Global Capital, LLC	7.21%	55,347	$2.2M
2	Versor Investments LP	5.04%	51,146	$2.1M
3	Avoro Capital Advisors LLC	4.84%	12,222,222	$491.7M
4	Chicago Capital Management, LLC	4.77%	190,000	$5.8M
5	SUVRETTA CAPITAL MANAGEMENT, LLC	3.62%	3,518,471	$141.5M
6	Kryger Capital LLC	3.13%	1,100,000	$44.3M
7	Deep Track Capital, LP	2.98%	4,532,374	$182.3M
8	Twin Securities, Inc.	2.49%	127,440	$5.1M
9	TIG Advisors, LLC	2.33%	1,252,986	$50.4M
10	Beck Bode, LLC	2.13%	312,841	$12.6M
11	Absolute Gestao de Investimentos Ltda.	2.06%	450,000	$18.1M
12	ALPINE ASSOCIATES MANAGEMENT INC.	2.05%	864,000	$34.8M
13	Kynam Capital Management, LP	2.05%	825,000	$33.2M
14	Exome Asset Management LLC	1.78%	85,517	$3.4M
15	Slotnik Capital, LLC	1.59%	135,000	$5.4M
16	RTW INVESTMENTS, LP	1.48%	3,685,045	$148.2M
17	HBK INVESTMENTS L P	1.45%	3,550,000	$142.8M
18	GARDNER LEWIS ASSET MANAGEMENT L P	1.44%	165,000	$6.6M
19	BCK CAPITAL MANAGEMENT LP	1.40%	8,000	$322K
20	SPHERA FUNDS MANAGEMENT LTD.	1.37%	214,914	$8.6M
21	HARVEST MANAGEMENT LLC	1.36%	70,000	$2.8M
22	ODDO BHF ASSET MANAGEMENT SAS	1.31%	825,000	$33.2M
23	GABELLI & Co INVESTMENT ADVISERS, INC.	1.20%	200,600	$8.1M
24	FNY Investment Advisers, LLC	1.11%	63,092	$3K
25	GLAZER CAPITAL, LLC	1.10%	1,294,196	$52K

Investor	Ownership History	% of Portfolio	Prev %	Rank	Conviction	Avg Buy Price	13F Score™ 3Y / 7Y	Sell Timing	Shares	Mkt Value	Change	Change %	Source	Quarter	Filed

Frequently Asked Questions — APELLIS PHARMACEUTICALS INC (APLS)

What does the Smart Money Trend signal show for APLS?

Buying streak — 3 quarters in a row: For 3 consecutive quarters, more hedge funds added APLS than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for APLS?

Slight buying edge — 58% buying: Last quarter: 219 funds bought or added vs 157 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for APLS holders?

Strong quality — 31% AUM from major funds: 49 of 320 holders rank in the top 100 by AUM, accounting for 31% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held APLS?

48% of holders stayed for 2+ years: 155 out of 320 hedge funds have held APLS for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Market Cap	--
Enterprise Value	--
Trailing P/E	--
Forward P/E	--
PEG Ratio (5yr expected)	--
Price/Sales (ttm)	--
Price/Book (mrq)	--
Enterprise Value/Revenue	--
Enterprise Value/EBITDA	--
Beta (5Y Monthly)	--
Short Ratio (Days to Cover)	--
Short % of Float	--

Profit Margin	--
Return on Assets (ttm)	--
Return on Equity (ttm)	--

Revenue (ttm)	--
Net Income Avi to Common (ttm)	--
Diluted EPS (ttm)	--
Total Cash (mrq)	--
Total Debt/Equity (mrq)	--
Levered Free Cash Flow (ttm)	--

APELLIS PHARMACEUTICALS INC (APLS)

Smart Money Signals — APLS

Buying streak — 3 quarters in a row

At the ownership peak (100% of max)

Fast accumulation — +28% more funds vs a year ago

Slight buying edge — 58% buying

More new buyers each quarter (+57 vs last Q)

48% of holders stayed for 2+ years

Value +66% but shares only +6% — price-driven

Acceleration phase — new buyers rushing in

Deep conviction — 60% of holders stayed 2+ years

Strong quality — 31% AUM from major funds

Institutional Sentiment Summary — APLS

Hedge Fund Ownership: APLS

Market Analysis: APLS

Analyst Price Targets

Analyst Recommendations

Stock Performance

Company Profile: APLS

Hedge Fund Positioning: APLS

Statistics: APLS

Valuation Measures Data as of: --

Financial Highlights

Institutional Holders (2026 Q1)

Frequently Asked Questions — APELLIS PHARMACEUTICALS INC (APLS)

Welcome to 13Foresight!